Development of Liposome-Based Immunoassay for the Detection of Cardiac Troponin I

Cardiovascular diseases (CVDs) are one of the foremost causes of mortality in intensive care units worldwide. The development of a rapid method to quantify cardiac troponin I (cTnI)—the gold-standard biomarker of myocardial infarction (MI) (or “heart attack”)—becomes crucial in the early diagnosis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Radha, Remya, Al-Sayah, Mohammad Hussein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623906/
https://www.ncbi.nlm.nih.gov/pubmed/34834080
http://dx.doi.org/10.3390/molecules26226988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623906/
https://www.ncbi.nlm.nih.gov/pubmed/34834080
http://dx.doi.org/10.3390/molecules26226988

Ejemplares similares